MAXIM PHARMACEUTICALS INC (CIK: 0001013351) EDGAR, Information, Filings... CompaniesBIO.Com

MAXIM PHARMACEUTICALS INC

Mailing address
8899 UNIVERSITY CENTER LANE, STE 400, SAN DIEGO, Delaware, 92122
Phone
8584534040
State location
California
State of incorporation
Delaware
Fiscal year end
September 30
SIC
2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Filings
N/A

MAXIM PHARMACEUTICALS INC (CIK: 0001013351) is an American company incorporated in the state of California. Head office is located at 8899 UNIVERSITY CTR LANE, STE 400, SAN DIEGO, California, 92122. Work in the industry 2833 - (CF Office: Office of Life Sciences) MEDICINAL CHEMICALS & BOTANICAL PRODUCTS. MAXIM PHARMACEUTICALS INC is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
YETTER WAYNE P	0001215120	Jan-04-2006	director
TOWNSEN FULTON DUWAINE	0001215911	Jan-04-2006	director
MARTENSSON PEROLAF	0001215912	Jan-04-2006	director
ZERBE ROBERT L MD	0001220363	Jan-04-2006	director
Bedard John F	0001305387	Jan-04-2006	director
Prunty John D	0001306376	Jan-04-2006	officer: Chief Financial Officer
STAMBAUGH LARRY G	0001215909	Aug-03-2005	officer: Chairman,CEO and President
FRASHIER GARY E	0001215914	Feb-19-2004	director
HEINRICHS THEODOR H	0001215916	Feb-19-2004	director
TONETTA SHARON A	0001271326	Dec-01-2003	officer: V.P.,Drug Development
GEHLSEN KURT R	0001215906	Nov-20-2003	officer: Chief Scientific Officer
ALTIG ANTHONY E	0001215907	Nov-20-2003	officer: Chief Financial Officer
GLEASON PAMELA GEE	0001215908	Nov-20-2003	officer: Vice President, Human Resource

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by MAXIM PHARMACEUTICALS INC

Filings	Format	Description	Filed/Effective	File/Film Number
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001057 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001052 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001051 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001045 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001044 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001043 ( Act) Size: 0 KB	Jan-06-2006
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001104659-06-001042 ( Act) Size: 0 KB	Jan-06-2006
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001104659-06-000409 (34 Act) Size: KB	Jan-05-2006	001-14430 06509253
8-K	Document	Current report filing Acc-no: 0001104659-05-062019 (34 Act) Size: KB	Dec-21-2005	001-14430 051278404
10-K	Document	Annual report pursuant to section 13 and 15(d) Acc-no: 0001104659-05-060826 (34 Act) Size: KB	Dec-14-2005	001-14430 051264541
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014729 (34 Act) Size: KB	Dec-14-2005	001-14430 051263199
8-K	Document	Current report filing Acc-no: 0001104659-05-060710 (34 Act) Size: KB	Dec-14-2005	001-14430 051262995
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014512 (34 Act) Size: KB	Dec-08-2005	001-14430 051250793
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014509 (34 Act) Size: KB	Dec-08-2005	001-14430 051250777
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014375 (34 Act) Size: KB	Dec-05-2005	001-14430 051242242
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014260 (34 Act) Size: KB	Dec-01-2005	001-14430 051235702
DEFA14A	Document	Additional definitive proxy solicitation materials Acc-no: 0000950123-05-014141 (34 Act) Size: KB	Nov-28-2005	001-14430 051229166
425	Document	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0000950123-05-013643 (34 Act) Size: 0 KB	Nov-14-2005	001-14430 051202773
425	Document	Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions Acc-no: 0000950123-05-013641 (34 Act) Size: 0 KB	Nov-14-2005	001-14430 051202737
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0000950123-05-013492 (34 Act) Size: KB	Nov-10-2005	001-14430 051195131

Recent 20 filings. View all MAXIM PHARMACEUTICALS INC filings

Overall rating 5.0

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

MAXIM PHARMACEUTICALS INC overview
MAXIM PHARMACEUTICALS INC job
MAXIM PHARMACEUTICALS INC stock
MAXIM PHARMACEUTICALS INC ownership
MAXIM PHARMACEUTICALS INC CEO
MAXIM PHARMACEUTICALS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.